Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
US6506724B1 · kind B1 · utility
109Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 1999 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Jun 1, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.